Deal Team

Finance
Corporate
Capital Markets
Tax

AbbVie in its $8 billion senior notes offering

On February 24, 2026, AbbVie, Inc. priced a registered public offering of $8.0 billion aggregate principal amount of senior unsecured notes.  AbbVie intends to use the net proceeds from the offering to repay amounts outstanding under its 364-day delayed draw term loan facility and for general corporate purposes.  J.P. Morgan Securities LLC, BofA Securities, Inc., Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC are acting as joint book-running managers of the offering.

Wachtell, Lipton, Rosen & Katz is serving as legal advisor to AbbVie.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.